Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fujisawa USA Inc.

Division of Astellas Pharma Inc.

Latest From Fujisawa USA Inc.

At Last, Liposomes

The Liposome Company's, Sequus', and NeXstar's liposome products do overlap. Without differential clinical data, the perception of the equivalence is bound to influence the market. These companies are learning the hard lesson of the limitations inherent in relying on a single technology.
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Astellas Pharma Inc.
  • Senior Management
  • Noboru Maeda, PhD, Pres. & CEO
    Rich Tajak, CFO
    George Zorich, Sr. Dir., Bus. Dev.
    Kurt Lewis, VP, Mktg.
    James Shook, MD, PhD, VP, R&D
  • Contact Info
  • Fujisawa USA Inc.
    Phone: (847) 317-8800
    3 Parkway North
    Deerfield, IL 60015-2548
    USA
UsernamePublicRestriction

Register